Article
Genome-wide association study identifies two loci influencing plasma neurofilament light levels.
BMC medical genomics - 10 May 2018
Li Jie-Qiong, Yuan Xiang-Zhen, Li Hai-Yan, Cao Xi-Peng, Yu Jin-Tai, Tan Lan, Chen Wei-An
Abstract excerpt
BACKGROUND: Plasma neurofilament light (NFL) is a promising biomarker for Alzheimer disease (AD), which increases in the early stage of AD and is associated with the progression of AD. We performed a genome-wide association study (GWAS) of plasma NFL in Alzheimer's Disease Neuroimaging Initiative 1 (ADNI-1) cohort to identify novel variants associated with AD. METHODS: This study included 179 cognitively healthy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
